Detalhe da pesquisa
1.
A dosimetric comparison of the use of equally spaced beam (ESB), beam angle optimization (BAO), and volumetric modulated arc therapy (VMAT) in head and neck cancers treated by intensity modulated radiotherapy.
J Appl Clin Med Phys
; 20(11): 121-130, 2019 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-31593367
2.
Clinical utility of plasma Epstein-Barr virus DNA and ERCC1 single nucleotide polymorphism in nasopharyngeal carcinoma.
Cancer
; 121(16): 2720-9, 2015 Aug 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-25946469
3.
Sonographic appearance of thyroid glands in patients treated with intensity-modulated radiotherapy or conventional radiotherapy for nasopharyngeal carcinoma.
J Clin Ultrasound
; 43(4): 210-223, 2015 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-25138465
4.
A comprehensive dosimetric evaluation of using RapidArc volumetric-modulated arc therapy for the treatment of early-stage nasopharyngeal carcinoma.
J Appl Clin Med Phys
; 13(6): 3887, 2012 Nov 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-23149781
5.
Exploratory Study of NPC-0501 Trial: Optimal Cisplatin Dose of Concurrent and Induction/Adjuvant Chemotherapy for Locoregionally Advanced Nasopharyngeal Carcinoma.
Clin Cancer Res
; 28(12): 2679-2689, 2022 06 13.
Artigo
em Inglês
| MEDLINE | ID: mdl-35381064
6.
Dietary Pattern at 18-Month Post-Diagnosis and Outcomes of Breast Cancer Among Chinese Women with Early-Stage Breast Cancer.
Cancer Manag Res
; 13: 4553-4565, 2021.
Artigo
em Inglês
| MEDLINE | ID: mdl-34135632
7.
Treatment outcomes of nasopharyngeal carcinoma in modern era after intensity modulated radiotherapy (IMRT) in Hong Kong: A report of 3328 patients (HKNPCSG 1301 study).
Oral Oncol
; 77: 16-21, 2018 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-29362121
8.
Analysis of Plasma Epstein-Barr Virus DNA in Nasopharyngeal Cancer After Chemoradiation to Identify High-Risk Patients for Adjuvant Chemotherapy: A Randomized Controlled Trial.
J Clin Oncol
; : JCO2018777847, 2018 Jul 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-29989858
9.
Preliminary results of radiation dose escalation for locally advanced nasopharyngeal carcinoma.
Int J Radiat Oncol Biol Phys
; 64(2): 374-81, 2006 Feb 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-16213105
10.
Concurrent and adjuvant chemotherapy for nasopharyngeal carcinoma: a factorial study.
J Clin Oncol
; 22(13): 2643-53, 2004 Jul 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-15226332
11.
A new approach to computing normal tissue complication probability of an intensity-modulated radiotherapy treatment with stereotactic radiotherapy boost of nasopharyngeal carcinoma: a case study.
Med Dosim
; 36(2): 138-44, 2011.
Artigo
em Inglês
| MEDLINE | ID: mdl-20510601
12.
Survival outcome of patients with nasopharyngeal carcinoma with first local failure: a study by the Hong Kong Nasopharyngeal Carcinoma Study Group.
Head Neck
; 27(5): 397-405, 2005 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-15726589
13.
Treatment outcome for synchronous locoregional failures of nasopharyngeal carcinoma.
Head Neck
; 25(7): 585-94, 2003 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-12808662
14.
Intensity-modulated radiotherapy for early-stage nasopharyngeal carcinoma: a prospective study on disease control and preservation of salivary function.
Cancer
; 101(7): 1584-93, 2004 Oct 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-15378492